PM

Puneet Mahajan

Active Director Director DIN 05142653
DIN 05142653 First appointment Dec 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Dec 2011
Shareholding value •••• Premium profile

About Puneet Mahajan

Data last updated:

Puneet Mahajan is a Director at Alisier Drugs Private Limited (since 2011) and Director at Voopar Sciences Private Limited (since 2017). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹4.70 Cr; the largest is Alisier Drugs Private Limited at ₹3.06 Cr (FY 2024). Earlier, Puneet Mahajan was a Director at Evantis Lifesciences Private Limited (2016–2020) and Director at Torance Health Care Private Limited (2015–2017) and 3 more.

DIN 05142653
Primary Designation Director
Industry Pharma
First Appointment 28 Dec 2011
Oldest Company Age 14 yrs
Largest company Alisier Drugs Private Limited · ₹3.06 Cr (FY 2024)
Combined revenue ₹4.70 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alisier Drugs Private Limited U24232HR2011PTC044698
Director28 Dec 20112011₹3.06 Cr (FY 2024)Active
Voopar Sciences Private Limited U24304HR2017PTC071167
Director17 Oct 20172017₹1.64 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Evantis Lifesciences Private Limited U51397HR2016PTC058221
Director16 Feb 20162016₹6.6 Lakh (FY 2023)Active
Torance Health Care Private Limited U24232HR2015PTC055916
Director30 Jun 20152015₹3.00 Cr (FY 2025)Active
Zerdia Healthcare Private Limited U24304HR2016PTC064727
Director23 Jun 20162016₹1.66 Cr (FY 2025)Active
Director26 Feb 20142014₹86.8 Lakh (FY 2025)Active
Raosch Lifesciences Private Limited U24100HR2019PTC078599
Director18 Feb 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Puneet Mahajan

Directorship timeline

Open interactive timeline →
Raosch Lifesciences Private Limited
Alisier Drugs Private Limited
Voopar Sciences Private Limited
Evantis Lifesciences Private Limited
Premium access

Shareholding and investment profile for Puneet Mahajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Puneet Mahajan

Puneet Mahajan currently holds 2 directorships: Alisier Drugs Private Limited (Director, since 28 Dec 2011, revenue ₹3.06 Cr (FY 2024)); Voopar Sciences Private Limited (Director, since 17 Oct 2017, revenue ₹1.64 Cr (FY 2024)).

Puneet Mahajan was first appointed on 28 Dec 2011 as Director at Alisier Drugs Private Limited. The most recent appointment on record is 18 Feb 2019 at Raosch Lifesciences Private Limited.

The 2 current companies of Puneet Mahajan that report revenue have a combined latest revenue of ₹4.70 Cr: Alisier Drugs Private Limited ₹3.06 Cr (FY 2024); Voopar Sciences Private Limited ₹1.64 Cr (FY 2024).

Puneet Mahajan held 5 earlier board appointments: Evantis Lifesciences Private Limited (Director, 16 Feb 2016 to 12 Feb 2020); Torance Health Care Private Limited (Director, 30 Jun 2015 to 23 May 2017); Zerdia Healthcare Private Limited (Director, 23 Jun 2016 to 18 Feb 2019); Jonas Pharmaceuticals Private Limited (Director, 26 Feb 2014 to 27 Feb 2019); Raosch Lifesciences Private Limited (Director, from 18 Feb 2019).

The current boards of Puneet Mahajan's companies include Renu Sinha (Alisier Drugs Private Limited), Varesh Khanna (Alisier Drugs Private Limited), Ritu Chawla (Voopar Sciences Private Limited), Vaishali Mahajan (Voopar Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available